Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.

Raw, Rachael K; Rees, Jon; Kelly, Clive A; Wroe, Caroline; Chadwick, David R

Raw, Rachael K; Rees, Jon; Kelly, Clive A; Wroe, Caroline; Chadwick, David R.

Afiliação

Raw RK; School of Medicine and Health, Newcastle University, Newcastle upon Tyne, UK. Electronic address: Rachael.raw3@nhs.net.
Rees J; The School of Psychology, University of Sunderland, UK.
Kelly CA; The Department of Rheumatology, James Cook University Hospital, Middlesbrough, UK.
Wroe C; The Department of Nephrology, James Cook University Hospital, Middlesbrough, UK.
Chadwick DR; Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, UK.

Vaccine ; 40(3): 418-423, 2022 01 24.

Article em En | MEDLINE | ID: mdl-34895935

Assuntos

Vacina BNT162; COVID-19; Vacinas contra COVID-19; Feminino; Humanos; SARS-CoV-2; Hesitação Vacinal

Palavras-chave

COVID-19; COVID-19 Vaccination; Long-COVID; SARS-CoV-2; Vaccine Hesitancy; Vaccine-Associated Adverse Events

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Qualitative_research / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google